Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil in Recent Onset Type 1 Diabetes
NCT02372253Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Feb 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verapamil in type 1 diabetes mellitus (T1D), sponsored by University of Alabama at Birmingham. Started Feb 2015; status: completed.
02
Drugs
verapamil
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02372253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02372253.